Injective Struggles with Bearish Sentiment Despite Rally
Despite an 8% rally over the weekend, Injective's bearish outlook persists, with key resistance at $5.9 needing to be surpassed for a trend reversal.
Despite an 8% rally over the weekend, Injective's bearish outlook persists, with key resistance at $5.9 needing to be surpassed for a trend reversal.
May 2026 set a record for Bitcoin ETF inflows, signaling strong institutional interest and potential for price stabilization in the cryptocurrency market.
Phantom and Consensys challenge the OCC's stablecoin yield ban, aiming for balanced regulations amid fears of stifled innovation and consumer harm.
Aave's recovery reflects a resurgence in DeFi, though experts caution its support model may pose risks amid an evolving landscape in decentralized finance.
Kaspa is testing an essential support zone amid rising whale activity, raising hopes for a price reversal in the coming days as market sentiment shifts.
The Senate has finalized stablecoin yield regulations in the CLARITY Act, enhancing consumer protection and fostering innovation in the digital asset sector.
Bittensor's TAO token has surged 6.5%, prompting investors to consider bidding as bullish interest in AI tokens continues to rise in the crypto market.